241 blood cancer drugs are in the pipeline

04/29/2013 | Drug Store News

The pipeline of blood cancer treatments in clinical testing or being reviewed by the FDA includes 241 drugs, according to the Pharmaceutical Research and Manufacturers of America. Ninety-eight of the drugs are being developed for the treatment of lymphoma, while 97 are being developed for leukemia, 52 for multiple myeloma and 24 for other cancers of the bone marrow, blood and lymph nodes.

View Full Article in:

Drug Store News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX